Elsevier and InfoDesk Collaborate to Co-develop Federated Drug Pipeline Intelligence Solution

First Release to Integrate Comprehensive Drug Pipeline Data and Real-Time Intelligence From Multiple Content Sources in a Single Search

NEW YORK, June 7, 2010 - Elsevier, a world-leading healthcare and scientific publisher, announced
today that it has reached an agreement with Tarrytown, New York based
InfoDesk to co-develop a federated drug pipeline intelligence solution for
pharmaceutical and life science companies. The combination of Elsevier's
business intelligence expertise and InfoDesk's technological know-how paves
the way for the development of a powerful search and delivery tool that will
increase productivity and improve the quality of results, securely inside or
outside of a customer's firewall.

"We chose InfoDesk as our partner because they are content neutral and
excellent at supporting many diverse publishers, an essential capability
given our goal of developing a tool that can search multiple content sources.
They know how to take large feeds of data to help their clients deliver
information to their users," explains Gerry Stoia, President of Elsevier
Business Intelligence. "We're the content experts and they're the technology
experts so it makes for a good marriage. We're in this together and we're
very excited about working with the InfoDesk team."

In a competitive market where 'go, no go' decisions have enormous
financial implications, accurate, reliable data is mission critical. Building
on the sophisticated synonym index developed as part of the Universal
Integrator project initiated by Elsevier in 2007, InfoDesk will apply their
knowledge and experience to develop the new search tool. They anticipate the
first release will be available in the second half of 2010.

"We've noticed our pharmaceutical customers are frustrated with the way
drug pipeline data is presented," observes Sterling Stites, President and CEO
of InfoDesk. "There are many robust databases on the market, but with the
possible exception of a few information specialists, nobody actually likes
the process of using databases. Consequently, database usage stats are often
disappointing. The real demand is for useful information that answers the
user's question. What InfoDesk brings to the table is our unique ability to
'output' and actually 'push' content to users in a way that provides real
answers. That's what drives database usage."

There are three major benefits of a tool that can deliver accurate drug
pipeline results from multiple content sources in real-time from a single,
federated search.

Increased productivity

A fast, federated search of multiple content sources - either proprietary
or open access - will give users a single results set, increasing
productivity. With the new integrated solution, searches that used to take
days will take minutes.

Accurate results

Rich content drawn from a variety of sources will be filtered using
InfoDesk's advanced custom taxonomy, which can be modified to meet end-user
requirements. Elsevier's team of expert editors (MD and PhDs) will tag the
data at ingestion (when it is first compiled) and continuously monitor as the
sources are updated. In addition, customer-defined taxonomy for specific user
groups and individuals will further increase the relevance of results. What's
more, InfoDesk's intelligent algorithms will rationalize data by contrasting
and comparing results from multiple databases to ensure the reliability of
the results.

Increased security

Unlike other web-based products on the market today that are hosted
externally, Elsevier and InfoDesk's new product can be hosted or installed
inside a customer's firewall for greater security.

Additional modules are scheduled for release in 2011 and beyond which
will give customers the opportunity to expand their federated search and
integrate their proprietary internal data.

To learn more visit either Elsevier Business Intelligence (Booth # 1232)
or InfoDesk (Booth # 1422) at the Special Libraries Association (SLA) meeting
in New Orleans, Louisiana from 13 to 16 June. To download a complimentary
copy of a white paper that examines the benefits of a federated search visit
tinyurl.com/28jszgd.

About InfoDesk

InfoDesk (www.infodesk.com/) is a technology company that
specializes in providing secure, real-time, federated, personalized news and
information services to companies, government agencies and other
organizations.

Only InfoDesk's state-of-the-art content distribution platform combines
software products and applications for the acquisition, normalization and
processing of information with a comprehensive range of intuitive tools for
personalizing, receiving, viewing, searching, delivering and sharing
information in real-time.

For more than a decade, InfoDesk has been the preferred information
resource management solution at some of the world's top corporate and
government enterprises. InfoDesk is headquartered in Tarrytown, New York with
offices in London and Washington DC.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (www.thelancet.com) and Cell
(www.cell.com), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com),
Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and
Nursing Consult (www.nursingconsult.com), which enhance the
productivity of science and health professionals, and the SciVal suite
(www.scival.com) and MEDai's Pinpoint Review (www.medai.com),
which help research and health care institutions deliver better outcomes more
cost-effectively.

A global business headquartered in Amsterdam, Elsevier (
www.elsevier.com) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media Contact:

    Sean Smith
    Director of Marketing, InfoDesk
    +1-202-365-6832
    Sean.Smith@InfoDesk.com

Media Contact: Sean Smith, Director of Marketing, InfoDesk, +1-202-365-6832, Sean.Smith at InfoDesk.com .